Skip to main content

Want a detailed portfolio tracker?

Performance analysis of Magenta Therapeutics (MGTA)

Annual Return

Over the past 3 years, MGTA has had an average annual return of -2.03%, underperforming the benchmark SPY, which returned +5.39% annual.

Over the past 5 years, MGTA has had an average annual return of -72.09%, underperforming the benchmark SPY, which returned +4.19% annual.

Since Jun 21, 2018, MGTA has had an average annual return of -44.02%, underperforming the benchmark SPY, which returned +11.67% annual.

202320222021202020192018
+77.21%-91.08%-43.49%-48.29%+165.94%-60.74%

Monthly Return

YearJanFebMarAprMayJunJulAugSepOctNovDecAnnually Total
2023+38.60%+47.48%-1.62%-1.28%-17.41%+17.04%+5.75%-6.34%-6.77%+77.21%
2022-26.19%-3.69%-7.93%-50.68%-18.88%+3.38%+33.41%+9.98%-19.88%-8.55%-10.81%-65.66%-91.08%
2021+12.76%+18.89%+12.66%-1.61%+6.02%-20.81%-27.20%-10.11%+13.75%-12.09%-12.05%-21.31%-43.49%
2020-21.64%-1.01%-46.60%+29.78%+8.46%-15.05%-6.52%+3.56%-6.47%-7.20%+13.30%+9.65%-48.29%
2019+22.98%+87.01%+25.63%-12.51%+1.73%+0.61%-8.41%-23.54%-0.67%+1.46%+27.19%+14.51%+165.94%
2018-7.02%+1.85%+6.18%-17.74%-26.97%+11.52%-41.72%-60.74%

Drawdown analysis of Magenta Therapeutics (MGTA)

The maximum drawdown for the MGTA was -98.17%, occurring on Dec 29, 2022. This drawdown has not yet recovered.

The current MGTA drawdown is -96.45%.

Since Jun 21, 2018 MGTA has experienced the following drawdowns:

  • 50% or more: 2 times
  • 40% or more: 2 times
  • 30% or more: 2 times
  • 20% or more: 2 times
  • 10% or more: 5 times
DepthStartTo BottomBottomTo RecoverEndTotal
-98.17%Mar 25, 2019950Dec 29, 2022OngoingOngoingOngoing
-64.52%Aug 30, 201881Dec 27, 201845Mar 5, 2019126
-16.80%Jun 21, 201814Jul 12, 20186Jul 20, 201820
-16.30%Mar 6, 20196Mar 14, 20191Mar 15, 20197
-15.54%Jul 20, 201817Aug 14, 201812Aug 30, 201829
-3.41%Mar 18, 20192Mar 20, 20192Mar 22, 20194